👶
Our paediatric oncology program addresses the unique biology of childhood cancers, focusing on improving cure rates while reducing long-term treatment toxicity.
Learn MoreGenomic risk stratification to intensify treatment for high-risk patients while safely de-escalating therapy for standard-risk children.
Studying MYCN amplification, ALK mutations, and tumour microenvironment in high-risk neuroblastoma to identify novel therapeutic targets.
Long-term follow-up studies tracking endocrine, cardiac, and neurocognitive outcomes in childhood cancer survivors.
NCT06234508
RecruitingPI: Dr. Shirley Sunder Singh
NCT06234509
ActivePI: Dr. Selvaluxmy Ganapathy
Donations directly fund treatment for children from economically disadvantaged families and support research into gentler, more effective therapies.
Donate Now
.png&w=96&q=75){kind=small}